Diseases, Conditions, Syndromes

Omicron variant largely resistant to current antibodies

The omicron variant of SARS-CoV-2 is spreading at an alarming rate. It could soon replace the delta variant, which at present dominates globally. However, little is known about whether currently available vaccines and drugs ...

Oncology & Cancer

Gut bacteria key to fighting colorectal cancer, study suggests

Metabolites produced by gut bacteria during digestion can be used to trigger an immune response against colorectal cancer cells, according to new University of Alberta research, published in Frontiers in Immunology, that ...

Oncology & Cancer

Strengthening the immune response to cancer

For patients with lymphoma, multiple myeloma, or certain types of leukemia, treatment with chimeric antigen receptor T cells (CAR T cells) is sometimes the last chance of overcoming the cancer. The treatment involves taking ...

page 3 from 40